1Oen K,Duffy C M,Tse S M,et al.Early outcomes and improvement of patients with juvenile idiopathic arthritis enrolled in a Canadian multicenter inception cohort[J].Arthritis Care Res (Hoboken),2010,62(4):527-536.
2Horneff G,Burgos-Vargas R:Juvenile idiopathic arthritis.Subgroup characteristics and comparisons between rheumatoid arthritis-like subgroups and ankylosing spondylitis-like subgroups[J].Clin Exp Rheumatol,2009,27(4 Suppl 55):131-138.
2Feldmann M, Brennan F M, Maini R N. Rheumatoid arthritis [J]. Cell, 1996, 85(3): 307-310.
3Arnett F C, Edworthy S M, Bloch D A, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis [ J ]. Arthritis Rheum, 1988, 31 ( 3 ): 315 -324.
4Visser H, le Cessie S, Vos K, et al. How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis [J]. Arthritis Rheum, 2002, 46(2): 357-365.
5Niewold T B, Harrison M J, Paget S A. Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid arthritis [J].QJM, 2007, 100(4): 193-201.
6Arkfeld D G. Biological significance of anti-cyclic citrnllinated peptide antibody in rheumatoid arthritis [J]. Ann Intern Med, 2008, 148(5): 403-404.
7Schellekens G A, Visser H, de Jong B A, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide [J]. Arthritis Rheum, 2000, 43 (1): 155-163.
